(Q36898663)

17 August 2017

1 reference

title

Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response (English)

1 reference

17 August 2017

0 references

Alex J V Thompson

1 reference

17 August 2017

Stephen A Locarnini

series ordinal

1 reference

17 August 2017

publication date

31 July 2007

1 reference

Immunology & Cell Biology

17 August 2017

published in

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

435-445

1 reference

Antiviral signaling through pattern recognition receptors

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Innate Immunity: The Virtues of a Nonclonal System of Recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

A toll-like receptor that prevents infection by uropathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

The role of Toll-like receptors in the host response to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Recognition of cytosolic DNA activates an IRF3-dependent innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

TIR domain-containing adaptors define the specificity of TLR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Negative regulation of toll-like receptor-mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

IRF-7 is the master regulator of type-I interferon-dependent immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

VISA is an adapter protein required for virus-triggered IFN-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

TLR3 deletion limits mortality and disease severity due to Phlebovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Does Toll-like receptor 3 play a biological role in virus infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

TLR3 in antiviral immunity: key player or bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Recognition of single-stranded RNA viruses by Toll-like receptor 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Murine retroviruses activate B cells via interaction with toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

5'-Triphosphate RNA is the ligand for RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Picornavirus genome replication: assembly and organization of the VPg uridylylation ribonucleoprotein (initiation) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Cell type-specific involvement of RIG-I in antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

A target on the move: innate and adaptive immune escape strategies of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

mda-5, but not RIG-I, is a common target for paramyxovirus V proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

The hepatitis C virus life cycle as a target for new antiviral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Activation of anti-hepatitis C virus responses via Toll-like receptor 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Therapeutics targeting the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

A novel inhibitory peptide of Toll-like receptor signaling limits lipopolysaccharide-induced production of inflammatory mediators and enhances survival in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Identification of a peptide derived from vaccinia virus A52R protein that inhibits cytokine secretion in response to TLR-dependent signaling and reduces in vivo bacterial-induced inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Viruses and Toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Innate immune recognition of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

The Role of Toll‐Like Receptors in Herpes Simplex Infection in Neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

7 January 2021

Viral and nonviral uses of imiquimod: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

7 January 2021

Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

7 January 2021

Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

7 January 2021

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

7 January 2021

Subversion of the innate immune system by a retrovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

7 January 2021

MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100100

7 January 2021

Identifiers

DOI

10.1038/SJ.ICB.7100100

1 reference

17 August 2017

1 reference